StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research report released on Sunday. The firm issued a sell rating on the stock. Separately, HC Wainwright restated a buy rating and set a $3.00 price objective on shares of Moleculin Biotech in a report on Thursday, December 14th. Get Our […]
More Stories
Dollar General Beats Trend, Lifts Guidance as Higher-Income Shoppers Seek Bargains
By Panos Mourdoukoutas Shaking off concerns raised by several retailers over a potential shortfall in sales and earnings, Dollar General...
Super Bowl Champs Ronald Darby, David Andrews Top List of High-Profile NFL Retirements
By John Rigolizzo Super Bowl Champion cornerback Ronald Darby headlines a list of high-profile NFL retirements. The Houston Texans placed...
Job Openings Unexpectedly Jump to 7.39 Million in April: JOLTS
By Andrew Moran Employment vacancies unexpectedly rose in April, reaffirming the health of the U.S. labor market. According to the...
Job Openings Unexpectedly Jump to 7.39 Million in April: JOLTS
By Andrew Moran Employment vacancies unexpectedly rose in April, reaffirming the health of the U.S. labor market. According to the...
Mackenzie Financial Corp Purchases 18,555 Shares of Huntsman Co. (NYSE:HUN)
Mackenzie Financial Corp boosted its stake in Huntsman Co. (NYSE:HUN – Free Report) by 150.2% during the 4th quarter, Holdings...
Promising Battery Technology Stocks To Consider – June 1st
TETRA Technologies, Mullen Automotive, and Platinum Group Metals are the three Battery Technology stocks to watch today, according to MarketBeat’s...